Search

Hau Van Phan

Examiner (ID: 8779, Phone: (571)272-6696 , Office: P/3618 )

Most Active Art Unit
3618
Art Unit(s)
3618, 3613, 3615, 3619, 3611
Total Applications
2398
Issued Applications
1830
Pending Applications
100
Abandoned Applications
497

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18443568 [patent_doc_number] => 11679119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-20 [patent_title] => Bortezomib compositions [patent_app_type] => utility [patent_app_number] => 17/934901 [patent_app_country] => US [patent_app_date] => 2022-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20951 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934901 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/934901
Bortezomib compositions Sep 22, 2022 Issued
Array ( [id] => 18124763 [patent_doc_number] => 20230010375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-12 [patent_title] => ANTI-VIRAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/947314 [patent_app_country] => US [patent_app_date] => 2022-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3110 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17947314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/947314
ANTI-VIRAL COMPOSITION Sep 18, 2022 Pending
Array ( [id] => 18509923 [patent_doc_number] => 20230226009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => NEW COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE [patent_app_type] => utility [patent_app_number] => 17/940958 [patent_app_country] => US [patent_app_date] => 2022-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940958 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/940958
Combination comprising N-acetyl-L-cysteine and its use Sep 7, 2022 Issued
Array ( [id] => 18179922 [patent_doc_number] => 20230040651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => METAL (HYDR)OXIDE COMPOSITE COMPRISING POORLY SOLUBLE DRUG, METHOD FOR MANUFACTURING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 17/890796 [patent_app_country] => US [patent_app_date] => 2022-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18253 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 400 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890796 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/890796
Metal (hydr)oxide composite comprising poorly soluble drug, method for manufacturing same, and pharmaceutical composition comprising same Aug 17, 2022 Issued
Array ( [id] => 18683856 [patent_doc_number] => 11779566 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-10 [patent_title] => ST-246 (tecovirimat monohydrate) suspension formulations [patent_app_type] => utility [patent_app_number] => 17/864909 [patent_app_country] => US [patent_app_date] => 2022-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 19065 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864909 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/864909
ST-246 (tecovirimat monohydrate) suspension formulations Jul 13, 2022 Issued
Array ( [id] => 18434447 [patent_doc_number] => 20230181741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => RIFAXIMIN COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/862491 [patent_app_country] => US [patent_app_date] => 2022-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5618 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/862491
Rifaximin complexes Jul 11, 2022 Issued
Array ( [id] => 18412017 [patent_doc_number] => 11666544 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-06-06 [patent_title] => Compositions and methods for treating hypertension [patent_app_type] => utility [patent_app_number] => 17/857985 [patent_app_country] => US [patent_app_date] => 2022-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12570 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857985 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/857985
Compositions and methods for treating hypertension Jul 4, 2022 Issued
Array ( [id] => 17928221 [patent_doc_number] => 20220323346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => DISSOLVABLE POLYMERIC EYE INSERTS WITH A BIODEGRADABLE POLYMER AND METHOD OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/808342 [patent_app_country] => US [patent_app_date] => 2022-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17808342 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/808342
Dissolvable polymeric eye inserts with a biodegradable polymer and method of using the same Jun 22, 2022 Issued
Array ( [id] => 19554920 [patent_doc_number] => 20240366712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => GRIFFITHSIN FOR USE IN A METHOD OF PREVENTING OR TREATING INFECTIONS WITH RESPIRATORY VIRUSES [patent_app_type] => utility [patent_app_number] => 18/573294 [patent_app_country] => US [patent_app_date] => 2022-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9097 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573294 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/573294
GRIFFITHSIN FOR USE IN A METHOD OF PREVENTING OR TREATING INFECTIONS WITH RESPIRATORY VIRUSES Jun 21, 2022 Abandoned
Array ( [id] => 17911465 [patent_doc_number] => 20220313860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Additive Compositions for Pigmented Disinfection and Methods Thereof [patent_app_type] => utility [patent_app_number] => 17/845074 [patent_app_country] => US [patent_app_date] => 2022-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6207 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845074 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/845074
Additive compositions for pigmented disinfection and methods thereof Jun 20, 2022 Issued
Array ( [id] => 19216118 [patent_doc_number] => 20240180822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES [patent_app_type] => utility [patent_app_number] => 18/568694 [patent_app_country] => US [patent_app_date] => 2022-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18568694 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/568694
NON-NANOPARTICULATE APPLICATION FORMS OF MACROLIDES Jun 13, 2022 Pending
Array ( [id] => 18171758 [patent_doc_number] => 11571451 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-02-07 [patent_title] => Phytotherapeutic product for correction of symptom-complex of fibrocystic changes of mammary gland [patent_app_type] => utility [patent_app_number] => 17/839089 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3655 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839089 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/839089
Phytotherapeutic product for correction of symptom-complex of fibrocystic changes of mammary gland Jun 12, 2022 Issued
Array ( [id] => 18064370 [patent_doc_number] => 20220395457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS [patent_app_type] => utility [patent_app_number] => 17/836588 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46510 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836588 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836588
Dry powder formulations of epinephrine and associated methods Jun 8, 2022 Issued
Array ( [id] => 19297826 [patent_doc_number] => 20240226392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => PHOTOCURABLE DEVICES AND ADDITIVE MANUFACTURING METHODS OF MAKING THE SAME [patent_app_type] => utility [patent_app_number] => 18/561058 [patent_app_country] => US [patent_app_date] => 2022-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561058 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/561058
PHOTOCURABLE DEVICES AND ADDITIVE MANUFACTURING METHODS OF MAKING THE SAME Jun 7, 2022 Pending
Array ( [id] => 17865228 [patent_doc_number] => 20220287963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => Hydrocortisone Acetate Suppository Formulation For Treatment Of Disease [patent_app_type] => utility [patent_app_number] => 17/831946 [patent_app_country] => US [patent_app_date] => 2022-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12872 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17831946 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/831946
Hydrocortisone acetate suppository formulation for treatment of disease Jun 2, 2022 Issued
Array ( [id] => 19331181 [patent_doc_number] => 20240245611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => HARD-SHELL CAPSULE WITH INFLUX PREVENTION OF GASTRIC FLUIDS [patent_app_type] => utility [patent_app_number] => 18/563327 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563327 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563327
HARD-SHELL CAPSULE WITH INFLUX PREVENTION OF GASTRIC FLUIDS May 22, 2022 Pending
Array ( [id] => 19541610 [patent_doc_number] => 20240358646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => HARD SHELL CAPSULES WITH MODIFIED RELEASE COATING [patent_app_type] => utility [patent_app_number] => 18/563517 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18821 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18563517 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/563517
HARD SHELL CAPSULES WITH MODIFIED RELEASE COATING May 18, 2022 Pending
Array ( [id] => 17836234 [patent_doc_number] => 20220273539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING AND REVERSING ASPECTS OF AGING [patent_app_type] => utility [patent_app_number] => 17/745190 [patent_app_country] => US [patent_app_date] => 2022-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745190 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/745190
Compositions and methods for preventing and reversing aspects of aging May 15, 2022 Issued
Array ( [id] => 19359184 [patent_doc_number] => 20240261218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => BIODEGRADABLE MUCOADHESIVE PHARMACEUTICAL FORMULATIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 18/562374 [patent_app_country] => US [patent_app_date] => 2022-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20437 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562374 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/562374
BIODEGRADABLE MUCOADHESIVE PHARMACEUTICAL FORMULATIONS AND METHODS THEREOF May 12, 2022 Pending
Array ( [id] => 18347427 [patent_doc_number] => 20230135537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => NEBULIZATION FORMULATIONS FOR DELIVERY TO LOWER RESPIRATORY TRACT [patent_app_type] => utility [patent_app_number] => 17/740790 [patent_app_country] => US [patent_app_date] => 2022-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8066 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740790 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/740790
Nebulization formulations for delivery to lower respiratory tract May 9, 2022 Issued
Menu